These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 2571851

  • 1. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, Bassetti D.
    Lancet; 1989 Oct 14; 2(8668):926. PubMed ID: 2571851
    [No Abstract] [Full Text] [Related]

  • 2. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A, Propst T, Dietze O, Kathrein H, Judmeier G, Vogel W.
    Dig Dis Sci; 1995 Oct 14; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract] [Full Text] [Related]

  • 3. Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin.
    Schvarcz R, Weiland O, Glaumann H.
    Scand J Infect Dis; 1988 Oct 14; 20(2):231-2. PubMed ID: 2456609
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
    Veerabagu MP, Finkelstein SD, Rabinovitz M.
    Dig Dis Sci; 1997 Jul 14; 42(7):1445-8. PubMed ID: 9246044
    [Abstract] [Full Text] [Related]

  • 6. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis.
    Berris B, Feinman SV.
    Dig Dis Sci; 1991 Nov 14; 36(11):1657-60. PubMed ID: 1935507
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Further inquiry into treating hepatitis C with recombinant interferon alpha.
    Puoti C, Fuiano B, Annovazzi G, Pannullo A, Patane F.
    Ital J Gastroenterol; 1992 Feb 14; 24(2):111. PubMed ID: 1576363
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis.
    Craxi A, Di Marco V, Volpes R, Palazzo U.
    Hepatogastroenterology; 1988 Dec 14; 35(6):304-5. PubMed ID: 3063647
    [Abstract] [Full Text] [Related]

  • 12. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J, Inagaki Y, Suzuki M, Atsukawa K, Yonei Y, Tsukada N, Miyamoto K, Suzuki O, Kawamura Y, Kiryu Y.
    Nihon Shokakibyo Gakkai Zasshi; 1995 May 14; 92(5):899-903. PubMed ID: 7783385
    [No Abstract] [Full Text] [Related]

  • 13. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.
    Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K.
    Chest; 1994 Mar 14; 105(3):939-41. PubMed ID: 8131569
    [Abstract] [Full Text] [Related]

  • 14. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M, Miralles ES, de las Heras ME, Ledo A.
    J Dermatol; 1995 Jun 14; 22(6):461-2. PubMed ID: 7650248
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y, Shigemitsu T, Kajii N, Omura R, Harada T, Okita K.
    Intern Med; 1994 Oct 14; 33(10):637-40. PubMed ID: 7827383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.